CEACAM6 Antilichaam - middengebied: FITC (ARP41504_T100-FITC)

Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)

NCA, CEAL, CD66c

4680

P40199

NP_002474

Human

The immunogen is a synthetic peptide directed towards the middle region of human CEACAM6

Many breast, pancreatic, colonic and non-small-cell lung carcinoma lines express CEACAM6 and CEACAM5, and antibodies to both can affect tumor cell growth in vitro and in vivo. CEACAM6 expression is elevated in many solid tumors, but variable as a function of histotype. It may be a promising target for antibody-based therapy.

CARTPT; CEACAM6; CEACAM8; CEACAM7; CEACAM5; CEACAM1; APP

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

IHC, WB

0.5 mg/ml

Human: 100%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

38kDa

Muenzner, P., (2005) J. Cell Biol. 170 (5), 825-836

Wet Ice

344

CEACAM6

CEACAM6

Rabbit

Carcinoembryonic antigen-related cell adhesion molecule 6

NM_002483

EIQNPASANRSDPVTLNVLYGPDGPTISPSKANYRPGENLNLSCHAASNP